Daria M. Levina

Daria M. Levina

Auto-generated profile, based on publicly available information

Daria M. Levina

Department of Paediatrics and Paediatric Infectious Diseases Institute of Child's Health, Sechonov First Moscow State Medical University Moscow Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Russian Journal of Allergy
Verified
Journal Article
Open access
PDF file
DLDaria M. Levina
Daria M. Levina
IKIlya A. Korsunskiy
Ilya A. Korsunskiy
DMDaniel Munblit
Daniel Munblit
КАКорсунский Илья Анатольевич
Корсунский Илья Анатольевич
Food allergy is one of the most prevalent allergic conditions, causing reduction in patient quality of life. It is linked with high levels of anxiety due to potential life-threatening reactions, and high economic burden for a healthcare system. Food allergy affects approximately 5 to 10% of children around the world. In Russian Federation the diagnosis of food allergy is primarily based on clinical history, laboratory test results, examination and elimination of suspected food. Meanwhile oral food challenge (OFC) is considered a gold standard of food allergy diagnosis by most of professional bodies nationally and internationally. OFC is a diagnostic procedure involving administration of a causative allergen in gradually increasing amount under a close medical supervision. The method is safe, highly specific and sensitive and is widely used around the world for more than 45 years. The main goals of OFC include food allergy diagnosis and presence of tolerance evaluation, which may result in diet expansion. OFC may also help establishing both, reaction severity and dose needed to elicit reaction, which may further assist with alleviation of patients anxiety. In this paper we discuss existing approaches to the diagnosis of food allergy in Russian Federation and review available recommendations on OFC outlined in international guidelines.

5 October 2024 in Allergology and Immunology in Paediatrics
Verified
Journal Article
Open access
PDF file
LFL. A. Fyodorova
L. A. Fyodorova
YPYu. V. Petrova
Yu. V. Petrova
DLD. M. Levina
D. M. Levina
ИКИ. А. Корсунский
И. А. Корсунский
АКА. А. Корсунский
А. А. Корсунский
DMD. B. Munblit
D. B. Munblit
Relevance. Food allergy (FA) is an important public health concern, particularly among children, with an increasing prevalence. It is associated with a significant decrease in the quality of life for patients and their families due to the need to avoid allergens and the risk of severe allergic reactions, such as anaphylaxis. Despite active research, the primary treatment remains elimination diets, which limit patients’ options and highlight the need for new therapeutic solutions.Aim of the review. This review aims to summarize the current treatment methods for food allergy, discuss the challenges in evaluating the effectiveness of interventions, and highlight the importance of standardizing outcomes in clinical trials to improve comparability and practical relevance.Content. The review discusses modern therapeutic approaches for food allergy, such as oral, epicutaneous, and sublingual immunotherapies, which have shown positive results in achieving tolerance to allergens. Special attention is given to safety concerns, particularly for children, emphasizing the need for further research. The potential use of biological agents, such as omalizumab, in food allergy treatment is also explored. The review addresses challenges in choosing and standardizing endpoints in clinical trials, where most focus on desensitization and immunological markers, while patient-centered outcomes, such as quality of life, remain under-researched. The implementation of “core outcome sets” is highlighted as an important step toward improving data comparability and forming a more objective basis for clinical recommendations.Conclusions. The review emphasizes significant progress in food allergy treatment but notes the need for further research to ensure the safety of new therapies, particularly for children. Standardizing outcomes in clinical trials plays a key role in improving the quality and comparability of research, which will, in turn, help develop more effective clinical guidelines and improve patients’ quality of life.

22 November 2024 in Лечащий врач
Verified
Journal Article
Closed access
DLD.M. Levina
D.M. Levina
SLS.O. Lukyanova
S.O. Lukyanova
NZN.V. Zinovieva
N.V. Zinovieva
JPJ.V. Petrova
J.V. Petrova
MRM.A. Rumyantsev
M.A. Rumyantsev
LFL.A. Fedorova
L.A. Fedorova
Background. Food allergy is a serious, life-threatening condition that negatively impacts the quality of life of patients and their families, especially among children. In Europe, approximately 7 million people suffer from food allergy, while in Russia, the prevalence varies from 5% to 30%. Accurate diagnosis and treatment of food allergy are crucial to preventing complications and improving quality of life. Primary diagnostic methods include medical history, laboratory tests, and elimination diets, though each has its limitations. Globally, oral food challenges are considered the "gold standard" for food allergy diagnosis. It helps to establish a precise connection between the allergen and the reaction, reducing anxiety for patients and their families. Objective. To evaluate the feasibility of using oral food challenges as a diagnostic method for food allergies in children. Materials and methods. This single-center, prospective, interventional, non-randomized, uncontrolled study is being conducted from January 1, 2022, to December 31, 2024, at the G. N. Speransky Children’s Hospital No. 9 in Moscow. Children aged 6 months to 17 years, suspected of having an immediate allergic reaction to cow's milk protein and/or egg protein by a doctor or legal guardian, were invited to participate. The study involves using an open food challenge for diagnosing food allergies. An open food challenge involves consuming increasing amounts of the suspected allergen (milk, egg, etc.) in its natural form under medical supervision. To determine the necessity of a provocation test, a consultation is conducted, including a physical examination, medical history, and allergy testing (specific IgE blood tests, component diagnostics for milk and egg, and a prick test with the native allergen). Additionally, during the consultation, questionnaires on anxiety and quality of life were completed. Our patient selection and test procedure algorithm is an adapted version of existing protocols from international allergology organizations. Conclusions. Preliminary results indicate that the provocation test is a safe diagnostic method when following a strict patient selection and test procedure algorithm. Notably, parents of children undergoing these tests exhibit high anxiety levels. We plan to continue this study and assess personal and situational anxiety levels over time post oral food challenges.

2 July 2026 in Allergy
Verified
Journal Article
Open access
ALAgnes S. Y. Leung
Agnes S. Y. Leung
ETElizabeth Huiwen Tham
Elizabeth Huiwen Tham
KYKiwako Yamamoto
Kiwako Yamamoto
DCDerek K. Chu
Derek K. Chu
MNMatthew Norris
Matthew Norris
GWGary Wing‐Kin Wong
Gary Wing‐Kin Wong
Background: IgE‐mediated food allergy prevention guidelines are now established in many countries, but their implementation in routine clinical practice globally remains unclear. Methods: An anonymous online survey was distributed to healthcare professionals (HCPs) through the World Allergy Organization network between December 2024 and April 2025, collecting data on food allergy prevention recommendations in daily clinical practice. Results: The analysis included 731 healthcare professionals from 80 countries worldwide: Asia (36.7%), Europe (27.1%), North America (15.9%), and Rest of the World (20.0%; Russia, South America, Africa, Oceania). Unsupervised clustering revealed two distinct practice patterns—one favoring early allergen introduction and one favoring later introduction—with timing varying by allergen type. For peanuts, clusters diverged between early (median 6 months of age) and late (median 18 months of age) introduction recommendations for high‐risk infants. Allergen introduction timing was independently driven by region and specialty: North American HCPs recommend peanut introduction 6.7 months earlier than those in Asia (5.48 3.32 vs. 12.18 7.27 months; p < 0.001), and pediatric allergists globally advocate for introduction 2.37 months earlier than non‐allergists (8.72 5.85 vs. 11.09 7.14 months, p = 0.024). This disparity is more pronounced in high‐risk infants than in normal‐risk infants. Conclusions: The variability in allergen introduction practices, driven by geography and medical specialty, highlights a persistent gap in prevention guidelines adoption. This divergence likely reflects both suboptimal implementation of existing recommendations and regional differences in food allergy epidemiology. These findings underscore the need for population‐tailored allergen introduction strategies across diverse healthcare settings.